Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 28, 2015 7:03 PM ET

Pharmaceuticals

Company Overview of Emmaus Life Sciences, Inc.

Executive Profile

Yutaka Niihara M.D., M.P.H

Chairman and Chief Scientific Officer, Emmaus Life Sciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
55$250,000
As of Fiscal Year 2014

Background

Dr. Yutaka Niihara, M.D., M.P.H, has been Chief Scientific Officer of Emmaus Life Sciences, Inc. since May 1, 2015. Dr. Niihara served as the Chief Executive Officer and President of Emmaus Life Sciences, Inc. since May 5, 2011 until May 1, 2015. Dr. Niihara is a Clinical Professor of Medicine, Division of Medical Oncology/Hemotology at UCLA School of Medicine. Dr. Niihara was the Principal inventor of the patented L-glutamine therapy. Dr. Niihara has been involved in ...

Corporate Headquarters

21250 Hawthorne Boulevard
Torrance, California 90503

United States

Phone: 310-214-0065
Fax: 310-214-0075

Board Members Memberships

2011-Present
Chairman and Chief Scientific Officer

Education

BA 1982
Loma Linda University
MD 1986
Loma Linda University School of Medicine

Other Affiliations

Annual Compensation

Salary$250,000
Total Annual Compensation$250,000

Stocks Options

Exercisable Options$472,223
Unexercisable Options$277,777
Total Number of Options$750,000

Total Compensation

Total Annual Cash Compensation$250,000
Total Short Term Compensation$250,000
Total Calculated Compensation$250,000
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Emmaus Life Sciences, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.